series-a
Stage
1
Investors
About
Light Horse Therapeutics applies proprietary precision gene editing and target-agnostic functional screens to discover novel, chemically accessible small molecule targets for drug discovery, with an initial focus on challenging oncology targets.
Explore Light Horse Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.